EGFR-Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical Outcomes.

EGFR-Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical Outcomes. J Clin Oncol. 2019 02 01; 37(4):278-285.

View in: PubMed

subject areas

Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols
Biomarkers, Tumor
Carcinoma, Non-Small-Cell Lung
Class I Phosphatidylinositol 3-Kinases
ErbB Receptors
Female
Genetic Predisposition to Disease
Humans
Lung Neoplasms
Male
Middle Aged
Mutation
Neoplasm Grading
North America
Phenotype
Retinoblastoma Binding Proteins
Retrospective Studies
Small Cell Lung Carcinoma
Time Factors
Treatment Outcome
Tumor Suppressor Protein p53
Ubiquitin-Protein Ligases